559410 Sigma-AldrichSB 290157 - CAS 1140525-25-2 - Calbiochem
SB 290157, CAS 1140525-25-2, is a selective, high affinity, competitive antagonist of the anaphylatoxin C3a receptor (IC50 = 200 nM). Does not antagonize C5aR or other chemotactic GPCRs.
More>> SB 290157, CAS 1140525-25-2, is a selective, high affinity, competitive antagonist of the anaphylatoxin C3a receptor (IC50 = 200 nM). Does not antagonize C5aR or other chemotactic GPCRs. Less<<SB 290157 - CAS 1140525-25-2 - Calbiochem MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.
同义词: N²-[(2,2-Diphenylethoxy)acetyl]-L-arginine, TFA
Recommended Products
概述
| Replacement Information |
|---|
重要规格表
| CAS # | Empirical Formula |
|---|---|
| 1140525-25-2 | C₂₂H₂₈N₄O₄ · CF₃CO₂H |
Products
| 产品目录编号 | 包装 | 数量 / 包装 | |
|---|---|---|---|
| 559410-10MGCN | 塑胶安瓿;塑胶针药瓶 | 10 mg |
| References | |
|---|---|
| References | Ames, R.S., et al. 2001. J. Immunol. 166, 6341. |
| Product Information | |
|---|---|
| CAS number | 1140525-25-2 |
| ATP Competitive | N |
| Form | Lyophilized |
| Hill Formula | C₂₂H₂₈N₄O₄ · CF₃CO₂H |
| Chemical formula | C₂₂H₂₈N₄O₄ · CF₃CO₂H |
| Hygroscopic | Hygroscopic |
| Reversible | N |
| Structure formula Image | |
| Quality Level | MQ100 |
| Physicochemical Information | |
|---|---|
| Cell permeable | N |
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Product Usage Statements |
|---|
| Packaging Information | |
|---|---|
| Packaged under inert gas | Packaged under inert gas |
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| 产品目录编号 | GTIN |
| 559410-10MGCN | 04055977268140 |
Documentation
SB 290157 - CAS 1140525-25-2 - Calbiochem MSDS
| 职位 |
|---|
SB 290157 - CAS 1140525-25-2 - Calbiochem 分析证书
| 标题 | 批号 |
|---|---|
| 559410 |
参考
| 参考信息概述 |
|---|
| Ames, R.S., et al. 2001. J. Immunol. 166, 6341. |



